Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in Elderly or Frail Patients With AML Patients Treated With Azacitidine Plus Venetoclax
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Venetoclax
Related studies linked through entity extraction aliases.
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
- Status
- RECRUITING
- Phase
- PHASE2
Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML
- Status
- RECRUITING
- Phase
- PHASE1
Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Imetelstat Combinations in Relapsed AML
- Status
- RECRUITING
- Phase
- PHASE1
Efficacy and Safety of HMAs Combined With Venetoclax Versus HMAs Alone in ND Int-and H-risk MDS or CMML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE3
A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Venetoclax-containing Therapy Combined With Microtransplant for Intermediate-risk and Higher MDS
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
- Status
- RECRUITING
- Phase
- PHASE2
Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial
- Status
- RECRUITING
- Phase
- PHASE2
Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)
- Status
- RECRUITING
- Phase
- NA
High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)
- Status
- RECRUITING
- Phase
- PHASE1
HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2